231 related articles for article (PubMed ID: 25178985)
1. Sex steroid hormone metabolism in relation to risk of aggressive prostate cancer.
Black A; Pinsky PF; Grubb RL; Falk RT; Hsing AW; Chu L; Meyer T; Veenstra TD; Xu X; Yu K; Ziegler RG; Brinton LA; Hoover RN; Cook MB
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2374-82. PubMed ID: 25178985
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of sex hormone levels and risk of prostate cancer.
Gann PH; Hennekens CH; Ma J; Longcope C; Stampfer MJ
J Natl Cancer Inst; 1996 Aug; 88(16):1118-26. PubMed ID: 8757191
[TBL] [Abstract][Full Text] [Related]
3. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
[TBL] [Abstract][Full Text] [Related]
4. Sex hormones and the risk of incident prostate cancer.
Daniels NA; Nielson CM; Hoffman AR; Bauer DC;
Urology; 2010 Nov; 76(5):1034-40. PubMed ID: 20451981
[TBL] [Abstract][Full Text] [Related]
5. The association between serum sex steroid hormone concentrations and intraprostatic inflammation in men without prostate cancer and irrespective of clinical indication for biopsy in the placebo arm of the Prostate Cancer Prevention Trial.
Chadid S; Barber JR; Nelson WG; Gurel B; Lucia MS; Thompson IM; Goodman PJ; Stanczyk FZ; Parnes HL; Lippman SM; De Marzo AM; Platz EA
Prostate; 2020 Aug; 80(11):895-905. PubMed ID: 32506665
[TBL] [Abstract][Full Text] [Related]
6. Serum androgens and prostate cancer risk: results from the placebo arm of the Prostate Cancer Prevention Trial.
Schenk JM; Till C; Hsing AW; Stanczyk FZ; Gong Z; Neuhouser ML; Reichardt JK; Hoque AM; Figg WD; Goodman PJ; Tangen CM; Thompson IM
Cancer Causes Control; 2016 Feb; 27(2):175-82. PubMed ID: 26589415
[TBL] [Abstract][Full Text] [Related]
7. Associations of serum sex steroid hormone and 5α-androstane-3α,17β-diol glucuronide concentrations with prostate cancer risk among men treated with finasteride.
Kristal AR; Till C; Tangen CM; Goodman PJ; Neuhouser ML; Stanczyk FZ; Chu LW; Patel SK; Thompson IM; Reichardt JK; Hoque A; Platz EA; Figg WD; Van Bokhoven A; Lippman SM; Hsing AW
Cancer Epidemiol Biomarkers Prev; 2012 Oct; 21(10):1823-32. PubMed ID: 22879203
[TBL] [Abstract][Full Text] [Related]
8. Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers.
Zhou CK; Stanczyk FZ; Hafi M; Veneroso CC; Lynch B; Falk RT; Niwa S; Emanuel E; Gao YT; Hemstreet GP; Zolfghari L; Carroll PR; Manyak MJ; Sesterhenn IA; Levine PH; Hsing AW; Cook MB
Prostate; 2017 Dec; 77(16):1573-1582. PubMed ID: 28971497
[TBL] [Abstract][Full Text] [Related]
9. Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.
Yao S; Till C; Kristal AR; Goodman PJ; Hsing AW; Tangen CM; Platz EA; Stanczyk FZ; Reichardt JK; Tang L; Neuhouser ML; Santella RM; Figg WD; Price DK; Parnes HL; Lippman SM; Thompson IM; Ambrosone CB; Hoque A
Cancer Causes Control; 2011 Aug; 22(8):1121-31. PubMed ID: 21667068
[TBL] [Abstract][Full Text] [Related]
10. Selenium and Sex Steroid Hormones in a U.S. Nationally Representative Sample of Men: A Role for the Link between Selenium and Estradiol in Prostate Carcinogenesis?
Van Hemelrijck M; Sollie S; Nelson WG; Yager JD; Kanarek NF; Dobs A; Platz EA; Rohrmann S
Cancer Epidemiol Biomarkers Prev; 2019 Mar; 28(3):578-583. PubMed ID: 30482876
[TBL] [Abstract][Full Text] [Related]
11. Endogenous Circulating Sex Hormone Concentrations and Colon Cancer Risk in Postmenopausal Women: A Prospective Study and Meta-Analysis.
Mori N; Keski-Rahkonen P; Gicquiau A; Rinaldi S; Dimou N; Harlid S; Harbs J; Van Guelpen B; Aune D; Cross AJ; Tsilidis KK; Severi G; Kvaskoff M; Fournier A; Kaaks R; Fortner RT; Schulze MB; Jakszyn P; Sánchez MJ; Colorado-Yohar SM; Ardanaz E; Travis R; Watts EL; Masala G; Krogh V; Tumino R; Sacerdote C; Panico S; Bueno-de-Mesquita B; Gram IT; Waaseth M; Gunter MJ; Murphy N
JNCI Cancer Spectr; 2021 Dec; 5(6):. PubMed ID: 34805742
[TBL] [Abstract][Full Text] [Related]
12. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
[TBL] [Abstract][Full Text] [Related]
13. Prediagnostic serum hormones and the risk of prostate cancer.
Nomura A; Heilbrun LK; Stemmermann GN; Judd HL
Cancer Res; 1988 Jun; 48(12):3515-7. PubMed ID: 3370644
[TBL] [Abstract][Full Text] [Related]
14. Circulating steroid hormones and the risk of prostate cancer.
Severi G; Morris HA; MacInnis RJ; English DR; Tilley W; Hopper JL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):86-91. PubMed ID: 16434592
[TBL] [Abstract][Full Text] [Related]
15. Sex hormone levels and risk of breast cancer with estrogen plus progestin.
Farhat GN; Parimi N; Chlebowski RT; Manson JE; Anderson G; Huang AJ; Vittinghoff E; Lee JS; Lacroix AZ; Cauley JA; Jackson R; Grady D; Lane DS; Phillips L; Simon MS; Cummings SR
J Natl Cancer Inst; 2013 Oct; 105(19):1496-503. PubMed ID: 24041978
[TBL] [Abstract][Full Text] [Related]
16. Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.
Tang L; Yao S; Till C; Goodman PJ; Tangen CM; Wu Y; Kristal AR; Platz EA; Neuhouser ML; Stanczyk FZ; Reichardt JK; Santella RM; Hsing A; Hoque A; Lippman SM; Thompson IM; Ambrosone CB
Carcinogenesis; 2011 Oct; 32(10):1500-6. PubMed ID: 21771722
[TBL] [Abstract][Full Text] [Related]
17. Endogenous sex hormones and the risk of prostate cancer: a prospective study.
Weiss JM; Huang WY; Rinaldi S; Fears TR; Chatterjee N; Hsing AW; Crawford ED; Andriole GL; Kaaks R; Hayes RB
Int J Cancer; 2008 May; 122(10):2345-50. PubMed ID: 18172860
[TBL] [Abstract][Full Text] [Related]
18. Association of serum sex steroid receptor bioactivity and sex steroid hormones with breast cancer risk in postmenopausal women.
Fourkala EO; Zaikin A; Burnell M; Gentry-Maharaj A; Ford J; Gunu R; Soromani C; Hasenbrink G; Jacobs I; Dawnay A; Widschwendter M; Lichtenberg-Fraté H; Menon U
Endocr Relat Cancer; 2012 Apr; 19(2):137-47. PubMed ID: 22199143
[TBL] [Abstract][Full Text] [Related]
19. Endogenous sex hormones and prostate cancer: a collaborative analysis of 18 prospective studies.
; Roddam AW; Allen NE; Appleby P; Key TJ
J Natl Cancer Inst; 2008 Feb; 100(3):170-83. PubMed ID: 18230794
[TBL] [Abstract][Full Text] [Related]
20. Hormonal predictors of prostate cancer: a meta-analysis.
Shaneyfelt T; Husein R; Bubley G; Mantzoros CS
J Clin Oncol; 2000 Feb; 18(4):847-53. PubMed ID: 10673527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
